
### [MONDO:0017014](http://purl.obolibrary.org/obo/MONDO_0017014)
**Label:** interstitial lung disease specific to childhood

**Subclasses:** [MONDO:0018305](http://purl.obolibrary.org/obo/MONDO_0018305) (chronic granulomatous disease), [MONDO:0017017](http://purl.obolibrary.org/obo/MONDO_0017017) (primary interstitial lung disease specific to childhood due to alveolar vascular disorder), [MONDO:0012582](http://purl.obolibrary.org/obo/MONDO_0012582) (interstitial lung disease due to ABCA3 deficiency), [MONDO:0017016](http://purl.obolibrary.org/obo/MONDO_0017016) (primary interstitial lung disease specific to childhood due to alveolar structure disorder), [MONDO:0012580](http://purl.obolibrary.org/obo/MONDO_0012580) (hereditary pulmonary alveolar proteinosis), [MONDO:0017019](http://purl.obolibrary.org/obo/MONDO_0017019) (interstitial lung disease specific to infancy), [MONDO:0018458](http://purl.obolibrary.org/obo/MONDO_0018458) (familial hypocalciuric hypercalcemia), [MONDO:0016501](http://purl.obolibrary.org/obo/MONDO_0016501) (Hermansky-Pudlak syndrome with pulmonary fibrosis), [MONDO:0008054](http://purl.obolibrary.org/obo/MONDO_0008054) (myositis), [MONDO:0017024](http://purl.obolibrary.org/obo/MONDO_0017024) (secondary interstitial lung disease specific to childhood associated with a metabolic disease), [MONDO:0018456](http://purl.obolibrary.org/obo/MONDO_0018456) (polyarticular juvenile idiopathic arthritis), [MONDO:0017023](http://purl.obolibrary.org/obo/MONDO_0017023) (secondary interstitial lung disease specific to childhood associated with a granulomatous disease), [MONDO:0019432](http://purl.obolibrary.org/obo/MONDO_0019432) (rheumatoid factor-negative juvenile idiopathic arthritis), [MONDO:0017015](http://purl.obolibrary.org/obo/MONDO_0017015) (primary interstitial lung disease specific to childhood), [MONDO:0019433](http://purl.obolibrary.org/obo/MONDO_0019433) (Oligoarticular juvenile idiopathic arthritis), [MONDO:0017025](http://purl.obolibrary.org/obo/MONDO_0017025) (Langerhans cell histiocytosis specific to childhood), [MONDO:0017020](http://purl.obolibrary.org/obo/MONDO_0017020) (secondary interstitial lung disease specific to childhood associated with a systemic disease), [MONDO:0015052](http://purl.obolibrary.org/obo/MONDO_0015052) (primary interstitial lung disease specific to childhood due to pulmonary surfactant protein anomalies), [MONDO:0017022](http://purl.obolibrary.org/obo/MONDO_0017022) (secondary interstitial lung disease specific to childhood associated with a systemic vasculitis), [MONDO:0017021](http://purl.obolibrary.org/obo/MONDO_0017021) (secondary interstitial lung disease specific to childhood associated with a connective tissue disease), [MONDO:0007827](http://purl.obolibrary.org/obo/MONDO_0007827) (inclusion body myositis), [MONDO:0011429](http://purl.obolibrary.org/obo/MONDO_0011429) (juvenile rheumatoid arthritis), [MONDO:0011577](http://purl.obolibrary.org/obo/MONDO_0011577) (myopathy, proximal, and ophthalmoplegia), [MONDO:0011603](http://purl.obolibrary.org/obo/MONDO_0011603) (GNE myopathy), 

**Corr. equiv. classes:** [Orphanet:264704](http://www.orpha.net/ORDO/Orphanet_264704), [OMIM:160750](http://purl.obolibrary.org/obo/OMIM_160750), [Orphanet:264724](http://www.orpha.net/ORDO/Orphanet_264724), [OMIM:605637](http://purl.obolibrary.org/obo/OMIM_605637), [Orphanet:264665](http://www.orpha.net/ORDO/Orphanet_264665), [OMIM:604302](http://purl.obolibrary.org/obo/OMIM_604302), [Orphanet:85408](http://www.orpha.net/ORDO/Orphanet_85408), [Orphanet:231500](http://www.orpha.net/ORDO/Orphanet_231500), [Orphanet:264683](http://www.orpha.net/ORDO/Orphanet_264683), [OMIM:147421](http://purl.obolibrary.org/obo/OMIM_147421), [Orphanet:92](http://www.orpha.net/ORDO/Orphanet_92), [Orphanet:379](http://www.orpha.net/ORDO/Orphanet_379), [Orphanet:264719](http://www.orpha.net/ORDO/Orphanet_264719), [OMIM:610913](http://purl.obolibrary.org/obo/OMIM_610913), [Orphanet:611](http://www.orpha.net/ORDO/Orphanet_611), [Orphanet:264714](http://www.orpha.net/ORDO/Orphanet_264714), [Orphanet:264699](http://www.orpha.net/ORDO/Orphanet_264699), [Orphanet:264675](http://www.orpha.net/ORDO/Orphanet_264675), [OMIM:605820](http://purl.obolibrary.org/obo/OMIM_605820), [Orphanet:264694](http://www.orpha.net/ORDO/Orphanet_264694), [Orphanet:264670](http://www.orpha.net/ORDO/Orphanet_264670), [Orphanet:100049](http://www.orpha.net/ORDO/Orphanet_100049), [Orphanet:85410](http://www.orpha.net/ORDO/Orphanet_85410), [Orphanet:440402](http://www.orpha.net/ORDO/Orphanet_440402), [Orphanet:405](http://www.orpha.net/ORDO/Orphanet_405), [Orphanet:93672](http://www.orpha.net/ORDO/Orphanet_93672), [Orphanet:602](http://www.orpha.net/ORDO/Orphanet_602), [OMIM:610921](http://purl.obolibrary.org/obo/OMIM_610921), [Orphanet:264709](http://www.orpha.net/ORDO/Orphanet_264709), [Orphanet:404580](http://www.orpha.net/ORDO/Orphanet_404580), 

**Class expressions from DL-Learner:**

- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 28.48%
- Thing 28.47%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 28.47%
- [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 24.25%
- [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 24.21%
- [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) 24.18%
- [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 24.18%
- [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 24.18%
- [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 24.18%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 23.00%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 21.70%
- [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) 20.69%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) 20.54%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 20.19%
- [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 18.67%


